4. Woof JM, Burton DR. Human antibody-F
c receptor interactions illuminated by crystal structures. Nat Rev Immunol 2004;4:89-99.
10. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science 2003;301:1374-1377.
14. Uncini A, Kuwabara S. Nodopathies of the peripheral nerve: an emerging concept. J Neurol Neurosurg Psychiatry 2015;86:1186-1195.
16. Williams JP, Carlson NG, Greenlee JE. Antibodies in autoimmune human neurological disease: pathogenesis and immunopathology. Semin Neurol 2018;38:267-277.
18. Neufing PJ, Clancy RM, Jackson MW, Tran HB, Buyon JP, Gordon TP. Exposure and binding of selected immunodominant La/SSB epitopes on human apoptotic cells. Arthritis Rheum 2005;52:3934-3942.
21. Saiki O, Saeki Y, Tanaka T, Doi S, Hara H, Negoro S, et al. Development of selective IgM deficiency in systemic lupus erythematosus patients with disease of long duration. Arthritis Rheum 1987;30:1289-1292.
22. Sivri A, Hasçelik Z. IgM deficiency in systemic lupus erythematosus patients. Arthritis Rheum 1995;38:1713.
23. Asakura K, Pogulis RJ, Pease LR, Rodriguez M. A monoclonal autoantibody which promotes central nervous system remyelination is highly polyreactive to multiple known and novel antigens. J Neuroimmunol 1996;65:11-19.
24. Paz Soldán MM, Warrington AE, Bieber AJ, Ciric B, Van Keulen V, Pease LR, et al. Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair. Mol Cell Neurosci 2003;22:14-24.
26. Wilkinson PC, Zeromski J. Immunofluorescent detection of antibodies against neurones in sensory carcinomatous neuropathy. Brain 1965;88:529-583.
27. Waters P, Pettingill P, Lang B. Detection methods for neural autoantibodies. Handb Clin Neurol 2016;133:147-163.